✦ LIBER ✦

Progressive splenomegaly after epoprostenol therapy in portopulmonary hypertension

✍ Scribed by Findlay, James Y. ;Plevak, David J. ;Krowka, Michael J. ;Sack, Elizabeth M. ;Porayko, Michael K.

Book ID: 102467211
Publisher: Wiley (John Wiley & Sons)
Year: 1999
Tongue: English
Weight: 49 KB
Volume: 5
Category: Article
ISSN: 1074-3022
DOI: 10.1002/lt.500050517

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recurrent portopulmonary hypertension af

Recurrent portopulmonary hypertension after liver transplantation: Management with epoprostenol and resolution after retransplantation

✍ Daniel H. Kett; Rita C. Acosta; Michael A. Campos; Miguel J. Rodriguez; Andrew A 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Experience in combination therapy for po

Experience in combination therapy for portopulmonary hypertension in the young with intravenous epoprostenol and endothelin receptor antagonists

✍ Kogaki, Shigetoyo; Takahashi, Kunihiko; Mihara, Seiko; Ishii, Ryo; Higeno, Ryota 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Liver transplantation in patients with s

Liver transplantation in patients with severe portopulmonary hypertension treated with preoperative chronic intravenous epoprostenol

✍ Henkie P. Tan; Jay S. Markowitz; Robert A. Montgomery; William T. Merritt; Andre 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

Living-Donor Lobar Lung Transplantation

Living-Donor Lobar Lung Transplantation for Pulmonary Arterial Hypertension After Failure of Epoprostenol Therapy

✍ Hiroshi Date; Kengo Fukushima Kusano; Hiromi Matsubara; Aiko Ogawa; Hideki Fujio 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Improvement in pulmonary hemodynamics du

Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension

✍ Michael J. Krowka; Robert P. Frantz; Michael D. McGoon; Cathy Severson; David J. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Pulmonary hypertension associated with increased pulmonary vascular resistance (PVR) and occurring in the setting of portal hypertension is referred to as ''portopulmonary hypertension.'' Intravenous epoprostenol (prostacyclin) is a potent pulmonary and systemic vasodilator with antithrombotic prope

Haemodynamic effects of epoprostenol as

Haemodynamic effects of epoprostenol as an aerosol for therapy of pulmonary hypertension after cardiac surgery

✍ Marggraf, G.; Balzereit, A.; Friedrich, I.; Zerkowski, H.R.; Doetsch, N.; Reidem 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 111 KB